LUNG CANCER (NON-SMALL CELL)

This study compares three established treatments for lung tumors: surgery, targeted radiation, and a minimally invasive procedure that uses heat or cold to destroy tumors. It aims to see which approach works best for controlling cancer while preserving patients' breathing ability…

This large, late-stage trial is comparing a new two-drug combination (belrestotug + dostarlimab) against the current standard treatment (pembrolizumab) for people with advanced non-small cell lung cancer who have not had prior treatment. The main goals are to see if the new combi…

This study is testing new combinations of immunotherapy drugs for people with advanced non-small cell lung cancer who haven't had any prior treatment. It focuses on patients whose tumors have high levels of a protein called PD-L1. The main goal is to see how safe these drug combi…

This study is for people with advanced non-small cell lung cancer that has worsened despite standard immunotherapy and chemotherapy. It compares three treatment approaches to see which helps patients live longer: standard chemotherapy alone, chemotherapy plus one immunotherapy dr…

This study is testing whether adding the drug niraparib to standard pembrolizumab maintenance therapy helps people with advanced non-small cell lung cancer live longer without their cancer getting worse. It involves 666 adults whose cancer stabilized or shrank after initial chemo…

This study is testing whether providing medically tailored meals and nutrition counseling to vulnerable lung cancer patients can help them feel better during treatment. It aims to see if this support improves their diet, reduces treatment side effects, and enhances their overall …

This study is testing a 12-week home program designed to help people who have had non-small cell lung cancer and a supportive partner (like a family member or friend) get more active and manage stress. The program, called Breathe Easier+, provides remote coaching, guided walking,…